🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
Business: Second Sight Medical Products, Inc. develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The company's current product is an advanced neurostimulation device called the Argus II System, which treats retinitis pigmentosa. The Argus II System is the only retinal prosthesis approved in the United States by the FDA and the first approved retinal prosthesis in the world. The company seeks to treat all blind patients through further improvements to their neurostimulation platform.
Notes: Second Sight Medical Products, Inc.(EYES) has announced a 1-for-8 reverse stock split. As a result of the reverse stock split, each EYES Common Sharewill be converted into the right to receive 0.125 (New) Second Sight Medical Products, Inc. Common Shares.The reverse stock split will become effective before the market open on January 6, 2020.
Company Contact
- CEO
- Scott Dunbar
- CFO
- John T. Blake
- Headquarters
- 12744 San Fernando Road, Suite 400, Sylmar, CA 91342
- Phone
- 818-833-5000
- Fax
- 818-833-5067
- Investor Relations
- Lisa Wilson, In-Site Communications, Inc. · 212-452-2793 · lwilson@insitecony.com